{"nctId":"NCT01124643","briefTitle":"Extension Study of TKT028 Evaluating Safety and Clinical Outcomes of ReplagalÂ® in Adult Patients With Fabry Disease","startDateStruct":{"date":"2010-04-13","type":"ACTUAL"},"conditions":["Fabry Disease"],"count":35,"armGroups":[{"label":"Replagal 0.2 mg/kg EOW","type":"EXPERIMENTAL","interventionNames":["Biological: Replagal"]}],"interventions":[{"name":"Replagal","otherNames":["algalsidase alfa","alpha-Galactosidase","DRX005B"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Complete all study requirements and assessments for Study TKT028 less than 30 days (+/- 7 days) prior to the first dose in this extension protocol\n* Voluntarily signed an Institutional Review Board/Independent Ethics Committee- approved informed consent form after all relevant aspects of the study have been explained and discussed.\n* Has received and tolerated at least 80% of the total planned Replagal infusions in Study TKT028\n* Female participants of child-bearing potential must agree to use a medically acceptable method of contraception at all times during the study and must have a negative pregnancy test at the time of study entry and as required throughout participation in study\n\nExclusion Criteria:\n\n* Has received treatment with any investigational drug (other than Replagal) or device within 30 days prior to study entry.\n* Is unable to comply with the protocol, (eg, is unable to return for safety evaluations, or is otherwise unlikely to complete the study), as determined by the Investigator\n* Has a positive test for hepatitis B surface antigen (HBsAg), hepatitis C(HCV) antibody, or human immunodeficiency virus (HIV) antibody\n* Is pregnant or lactating\n* Is morbidly obese, defined as body mass index (BMI) \\>39 kg/m2\n* Has any safety or medical issues, as assessed by the Investigator, that contraindicate participation in the study (eg, has experienced an adverse reaction to treatment with Replagal or has a known hypersensitivity to any of the components of Replagal","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in Left Ventricular Mass Indexed to Height (LVMI)","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.75","spread":"13.46"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Maximal Oxygen Consumption (VO2max) at Peak Exercise","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.7","spread":"3.11"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Distance Walked in 6- Minute Walk Test (6MWT)","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-11.2","spread":"83.99"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in the Minnesota Living With Heart Failure Questionnaire (MLHF- Q)","description":"The MLHF-Q contains 21 questions with answers ranging from 0 (no) to 5 (very much). The final score ( 0 to 105) is the sum of the points for the 21 questions. A higher score indicates a worse quality of life.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.0","spread":"19.31"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in New York Heart Association (NYHA) Functional Class","description":"Class I: No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea. Class II: Slight limitation of physical activity. Comfortable at rest, but ordinary physical activity results in fatigue, palpitation, or dyspnea. Class III: Marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes fatigue, palpitation, or dyspnea. Class IV: Unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest. If any physical activity is undertaken, discomfort is increased.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"34","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Plasma Gb3","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.18","spread":"1.52"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in eGFR","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.25","spread":"10.22"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Albumin/Creatinine (A/Cr) Ratio","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"178.5","spread":"857.74"}]}]}]},{"type":"PRIMARY","title":"Safety Evaluations","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"32","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":6,"n":35},"commonTop":["Nasopharyngitis","Diarrhoea","Headache","Bronchitis","Pain in extremity"]}}}